PURPOSE: The purpose of this study is to identify dosimetric variables that best predict for acute esophagitis in patients treated for locally advanced non-small cell lung cancer in a prospectively accrued statewide consortium. METHODS AND MATERIALS: Patients receiving definitive radiation therapy for stage II-III non-small cell lung cancer within the Michigan Radiation Oncology Quality Consortium were included in the analysis. Dose-volume histogram data were analyzed to determine absolute volumes (cc) receiving doses from 10 to 60 Gy (V10, V20, V30, V40, V50, and V60), as well as maximum dose to 2 cc (D2cc), mean dose (MD), and generalized equivalent uniform dose (gEUD). Logistic regression models were used to characterize the risk of toxicity as a function of dose and other covariates. The ability of each variable to predict esophagitis, individually or in a multivariate model, was quantified by receiver operating characteristic analysis. RESULTS: There were 533 patients who met study criteria and were included; 437 (81.9%) developed any grade of esophagitis. Significant variables on univariate analysis for grade ≥2 esophagitis were concurrent chemotherapy, V20, V30, V40, V50, V60, MD, D2cc, and gEUD. For grade ≥3 esophagitis, the predictive variables were: V30, V40, V50, V60, MD, D2cc, and gEUD. In multivariable modeling, gEUD was the most significant predictor of both grade ≥2 and grade ≥3 esophagitis. When gEUD was excluded from the model, D2cc was selected as the most predictive variable for grade ≥3 esophagitis. For an estimated risk of grade ≥3 esophagitis of 5%, the threshold values for gEUD and D2cc were 59.3 Gy and 68 Gy, respectively. CONCLUSIONS: In this study, we report the novel finding that gEUD and D2cc, rather than MD, were the most predictive dose metrics for severe esophagitis. To limit the estimated risk of grade ≥3 esophagitis to <5%, thresholds of 59.3 Gy and 68 Gy were identified for gEUD and D2cc, respectively.
PURPOSE: The purpose of this study is to identify dosimetric variables that best predict for acute esophagitis in patients treated for locally advanced non-small cell lung cancer in a prospectively accrued statewide consortium. METHODS AND MATERIALS: Patients receiving definitive radiation therapy for stage II-III non-small cell lung cancer within the Michigan Radiation Oncology Quality Consortium were included in the analysis. Dose-volume histogram data were analyzed to determine absolute volumes (cc) receiving doses from 10 to 60 Gy (V10, V20, V30, V40, V50, and V60), as well as maximum dose to 2 cc (D2cc), mean dose (MD), and generalized equivalent uniform dose (gEUD). Logistic regression models were used to characterize the risk of toxicity as a function of dose and other covariates. The ability of each variable to predict esophagitis, individually or in a multivariate model, was quantified by receiver operating characteristic analysis. RESULTS: There were 533 patients who met study criteria and were included; 437 (81.9%) developed any grade of esophagitis. Significant variables on univariate analysis for grade ≥2 esophagitis were concurrent chemotherapy, V20, V30, V40, V50, V60, MD, D2cc, and gEUD. For grade ≥3 esophagitis, the predictive variables were: V30, V40, V50, V60, MD, D2cc, and gEUD. In multivariable modeling, gEUD was the most significant predictor of both grade ≥2 and grade ≥3 esophagitis. When gEUD was excluded from the model, D2cc was selected as the most predictive variable for grade ≥3 esophagitis. For an estimated risk of grade ≥3 esophagitis of 5%, the threshold values for gEUD and D2cc were 59.3 Gy and 68 Gy, respectively. CONCLUSIONS: In this study, we report the novel finding that gEUD and D2cc, rather than MD, were the most predictive dose metrics for severe esophagitis. To limit the estimated risk of grade ≥3 esophagitis to <5%, thresholds of 59.3 Gy and 68 Gy were identified for gEUD and D2cc, respectively.
Authors: Lawrence B Marks; Ellen D Yorke; Andrew Jackson; Randall K Ten Haken; Louis S Constine; Avraham Eisbruch; Søren M Bentzen; Jiho Nam; Joseph O Deasy Journal: Int J Radiat Oncol Biol Phys Date: 2010-03-01 Impact factor: 7.038
Authors: Richard Pötter; Christine Haie-Meder; Erik Van Limbergen; Isabelle Barillot; Marisol De Brabandere; Johannes Dimopoulos; Isabelle Dumas; Beth Erickson; Stefan Lang; An Nulens; Peter Petrow; Jason Rownd; Christian Kirisits Journal: Radiother Oncol Date: 2006-01-05 Impact factor: 6.280
Authors: Jean M Moran; Mary Feng; Lisa A Benedetti; Robin Marsh; Kent A Griffith; Martha M Matuszak; Michael Hess; Matthew McMullen; Jennifer H Fisher; Teamour Nurushev; Margaret Grubb; Stephen Gardner; Daniel Nielsen; Reshma Jagsi; James A Hayman; Lori J Pierce Journal: Pract Radiat Oncol Date: 2016-10-20
Authors: Shulian Wang; Zhongxing Liao; Xiong Wei; Helen H Liu; Susan L Tucker; Chao-Su Hu; Rodhe Mohan; James D Cox; Ritsuko Komaki Journal: Int J Radiat Oncol Biol Phys Date: 2006-09-25 Impact factor: 7.038
Authors: Anthony Brade; Robert MacRae; Scott A Laurie; Andrea Bezjak; Ronald Burkes; Quincy Chu; John R Goffin; John Cho; Andrew Hope; Alex Sun; Natasha Leighl; Stephanie Capobianco; Ronald Feld; Essai Mahalingam; Anwar Hossain; Neill Iscoe; Frances A Shepherd Journal: Clin Lung Cancer Date: 2015-12-21 Impact factor: 4.785
Authors: Tae Hyun Kim; Kwan Ho Cho; Hong Ryull Pyo; Jin Soo Lee; Ji Youn Han; Jae Ill Zo; Jong Mog Lee; Eun Kyoung Hong; Il Ju Choi; Sung Yong Park; Kyung Hwan Shin; Dae Yong Kim; Joo Young Kim Journal: Int J Radiat Oncol Biol Phys Date: 2005-07-15 Impact factor: 7.038
Authors: David A Palma; Suresh Senan; Cary Oberije; Jose Belderbos; Núria Rodríguez de Dios; Jeffrey D Bradley; R Bryan Barriger; Marta Moreno-Jiménez; Tae Hyun Kim; Sara Ramella; Sarah Everitt; Ramesh Rengan; Lawrence B Marks; Kim De Ruyck; Andrew Warner; George Rodrigues Journal: Int J Radiat Oncol Biol Phys Date: 2013-09-10 Impact factor: 7.038
Authors: Matthew D Fountain; Lisa M Abernathy; Fulvio Lonardo; Shoshana E Rothstein; Michael M Dominello; Christopher K Yunker; Wei Chen; Shirish Gadgeel; Michael C Joiner; Gilda G Hillman Journal: Front Oncol Date: 2015-10-21 Impact factor: 6.244
Authors: Suneetha Devpura; Aharon M Feldman; Samuel D Rusu; Essa Mayyas; Avielle Movsas; Stephen L Brown; Andrew Cook; Michael J Simoff; Zhen Sun; Mei Lu; Sean Vance; Munther I Ajlouni; M Salim Siddiqui; Indrin J Chetty; Benjamin Movsas Journal: Adv Radiat Oncol Date: 2021-09-29